Chronic Dyrk1 Inhibition Delays the Onset of AD-Like Pathology in 3xTg-AD Mice

Velazquez, R; Meechoovet, B; Ow, A; Foley, C; Shaw, A; Smith, B; Oddo, S; Hulme, C; Dunckley, T

Dunckley, T (reprint author), Arizona State Univ, Biodesign Inst, Neurodegenerat Dis Res Ctr, Tempe, AZ 85281 USA.

MOLECULAR NEUROBIOLOGY, 2019; 56 (12): 8364

Abstract

There is a critical need for new treatment approaches that can slow or prevent the progression of Alzheimer's disease (AD). Targets that act simultane......

Full Text Link